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Diabetes can result in loss of enteric neurons and subsequent gastrointestinal complications. The mechanism of enteric neuronal loss in diabetes is not known. We examined the effects of hyperglycemia on enteric
neuronal survival and the effects of glial cell line–derived neurotrophic factor (GDNF) on modulating this survival. Exposure of primary enteric neurons to 20 mM glucose (hyperglycemia) for 24 hours resulted in a significant increase in apoptosis compared with 5 mM glucose (normoglycemia). Exposure to 20 mM glucose resulted
in decreased Akt phosphorylation and enhanced nuclear translocation of forkhead box O3a (FOXO3a). Treatment of enteric neurons with GDNF ameliorated these changes. In streptozotocin-induced diabetic mice, there
was evidence of myenteric neuronal apoptosis and reduced Akt phosphorylation. Diabetic mice had loss of
NADPH diaphorase–stained myenteric neurons, delayed gastric emptying, and increased intestinal transit
time. The pathophysiological effects of hyperglycemia (apoptosis, reduced Akt phosphorylation, loss of inhibitory neurons, motility changes) were reversed in diabetic glial fibrillary acidic protein–GDNF (GFAP-GDNF)
Tg mice. In conclusion, we demonstrate that hyperglycemia induces neuronal loss through a reduction in Aktmediated survival signaling and that these effects are reversed by GDNF. GDNF may be a potential therapeutic
target for the gastrointestinal motility disorders related to diabetes.
*OUSPEVDUJPO
Diabetes mellitus is a common disorder and has a worldwide
prevalence of 6–7% (1, 2). Gastrointestinal dysfunction occurs
in as many as 75% of diabetic patients (3, 4). Some of the common gastrointestinal problems seen in diabetes include delayed
gastric emptying, diarrhea, constipation, and abdominal pain.
The pathogenesis of intestinal motility dysfunction in diabetes
remains unknown. The motility changes in the gastrointestinal
tract in diabetes are considered to be an expression of autonomic
neuropathy, with evidence for altered sympathetic function and
cholinergic denervation of the gastrointestinal tract (5–7), vagal
nerve dysfunction (8), sympathetic nerve damage (9), and damage
to the enteric nerves (10–12).
The pathological lesions that occur in the enteric neurons in
diabetes have been described. Loss of myenteric neurons has been
reported in short-term diabetes (13, 14). A reduction in specific
types of enteric neurons has been noted in several diabetic animal
models, including streptozotocin-induced (STZ-induced) diabetic rats (15, 16), STZ-induced diabetic mice (12), diabetic Chinese
hamsters (6), and the OLETF rat model of type 2 diabetes (11).
However, the mechanism underlying these changes in the enteric
nervous system (ENS) in diabetes is not well defined. Neuronal
Nonstandard abbreviations used: CA-Akt, constitutively active Akt; ChAT, choline
acetyltransferase; EFS, electric field–induced stimulation; ENS, enteric nervous
system; FOXO, forkhead box O; GDNF, glial cell line–derived neurotrophic factor;
GFAP, glial fibrillary acidic protein; NGF, nerve growth factor; nNOS, neuronal NO
synthase; p, phospho; p-EGFP, plasmid-enhanced GFP; STZ, streptozotocin; Tg-C,
GFAP-GDNF transgenic control; Tg-DM, GFAP-GDNF transgenic diabetic; WT-C,
WT control; WT-DM, WT diabetic mice.
Conflict of interest: The authors have declared that no conflict of interest exists.
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apoptosis appears to contribute to the neurodegeneration seen in
animal and cell culture models of diabetes (17). In the STZ model
of diabetes, evidence of increased apoptosis in the dorsal root ganglion neurons, myenteric neurons, and nodose ganglia of diabetic
rats has been demonstrated (18). Previous studies have shown that
high glucose levels injure neuronal cell types, including Schwann
cells, superior cervical ganglion neurons, and dorsal root ganglion
neurons (19, 20). However, the effects of hyperglycemia on enteric
neurons in culture have not been examined.
A reduction in neurotrophic factors can contribute to the changes noted in diabetic peripheral neuropathy (21, 22). Glial cell line–
derived neurotrophic factor (GDNF) is an important neurotrophic
factor for the ENS (23, 24). GDNF acts with the coreceptor glial
cell line–derived neurotrophic factor receptor α (GFRα1) to activate the Ret tyrosine kinase receptor, stimulating both the MAPK
and PI3K pathways (25). We and others have previously shown
that the proliferation, maturation, migration, and survival of the
enteric neurons are critically dependent on the activity of the Ret
tyrosine kinase receptor that is expressed in the developing and
mature enteric neurons (23, 25–27). GDNF-deficient mice also have
severe intestinal aganglionosis (24). GDNF overexpression in glial
fibrillary acidic protein–GDNF (GFAP-GDNF) Tg mice (Tg-DM
mice) prevents a subpopulation of spinal and cranial motor neurons from developmental programmed cell death and promotes
complete survival of injured neonatal neurons (28). One of the
major intracellular signaling pathways for neurotrophic factors
is the PI3K signaling pathway. GDNF activates the PI3K pathway
to promote enteric neuronal survival (26). Decreased PI3K signaling has been implicated in vagal afferent neurons in STZ-induced
diabetic rats (29). The effect of GDNF on diabetes-induced enteric
neuronal damage is not known.
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In this study, we looked for evidence of damage to the enteric
neurons in an experimental mouse model of diabetes as well as
the effects of hyperglycemia on primary enteric neurons in culture and the possible mechanisms underlying this neuronal injury.
The effects of the neurotrophic factor, GDNF, on hyperglycemiainduced toxicity was evaluated in vitro using primary enteric neurons in culture and in vivo using Tg mice overexpressing GDNF.
3FTVMUT
Hyperglycemia-induced apoptosis in enteric neurons is inhibited by GDNF.
We examined the effects of hyperglycemia on primary enteric neurons in culture. Enteric neurons from E14.5 rat guts were cultured
for 24 hours in the presence of different concentrations of glucose
(5, 10, or 20 mM) in serum-free/glucose-free media. These concentrations of glucose have been shown to evoke a significant depolarization in isolated enteric neurons (30). Cultured cells were then
fixed, and the effect of glucose on apoptosis of enteric neurons was
assessed by the Ret/Hoechst staining method (26). Hyperglycemia
caused a dose-dependent increase in enteric neuronal apoptosis
(Figure 1A). Hoechst is a nuclear stain that detects DNA fragmentation and condensation in cells undergoing apoptosis (Figure 1B).
Apoptosis was also assessed using the TUNEL method in conjuncThe Journal of Clinical Investigation

tion with staining for neurons with Ret. There was a significant
increase in apoptosis at the 20 mM glucose concentration compared with 5 mM glucose (Figure 1C). We next determined whether the neurotrophic factor GDNF can ameliorate hyperglycemiainduced apoptosis. In the presence of GDNF, the glucose-induced
apoptosis was significantly reduced (Figure 1C). To assess the role
of increased osmolarity in the hyperglycemic culture medium,
mannitol was used as an osmolar control. The increase in enteric
neuronal apoptosis (assessed by Ret/TUNEL staining) was secondary to hyperglycemia, but not secondary to hyperosmolarity, as the
addition of 15 mM mannitol did not significantly increase apoptosis compared with 5 mM glucose (Figure 1C). Representative
photographs of enteric neurons cultured in the presence of 5 mM
and 20 mM glucose and assessed for apoptosis using the TUNEL
method are shown (Figure 1D).
Hyperglycemia is associated with decreased Akt phosphorylation. We
next examined the role of the PI3K pathway in the glucose-induced
modulation of enteric neuronal apoptosis. GDNF is a known activator of the PI3K pathway in enteric neurons. Activation of the
PI3K pathway results in phosphorylation of Akt (26). Enteric neurons were cultured in medium containing 5 or 20 mM glucose in
the presence or absence of GDNF. Cells were fixed after culture for
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24 hours and stained using a primary antibody to phospho-Akt
(p-Akt). Peripherin was used as a neuronal marker. The percentage
of neurons staining positive for p-Akt was significantly reduced
in the presence of 20 mM glucose compared with 5 mM glucose.
The addition of GDNF significantly increased the p-Akt–stained
neurons as shown in Figure 2, A and B.
Hyperglycemia is associated with increased FOXO3a translocation.
One of the main downstream targets of Akt is the forkhead
family of transcription factors. Two members of the forkhead
box O (FOXO) subfamily of forkhead transcription factors,
FOXO1 and FOXO3a, critically regulate cellular differentiation
(31) and neuronal survival (32). Enteric neurons were cultured
in medium containing 5 or 20 mM glucose in the presence or
absence of GDNF. Cells were cultured for 24 hours, fixed, and
stained with primary antibody to FOXO3a and peripherin. The
percentage of neurons with nuclear translocation of forkhead
was significantly higher in 20 mM glucose compared with 5 mM
glucose. Addition of GDNF to the medium resulted in a significant reduction of forkhead nuclear translocation in the presence
of 20 mM glucose (Figure 3).

Expression of constitutively active Akt rescues hyperglycemia-induced
ENS apoptosis. To confirm the role of Akt in rescuing hyperglycemia-induced apoptosis in enteric neurons, cells were transfected
with a control plasmid-enhanced GFP (p-EGFP) vector or a constitutively active Akt (CA-Akt) construct (33) and cultured in the
presence of 5 mM or 20 mM glucose for 24 hours. Apoptosis was
evaluated using the Ret/TUNEL method. Overexpression of Akt
but not p-EGFP was able to rescue the enteric neurons from undergoing apoptosis in the presence of 20 mM glucose (Figure 4).
Diabetic mice exhibit enteric neuronal apoptosis and degeneration. In
order to verify the changes induced by hyperglycemia on enteric
neurons in culture and their reversal by GDNF in vivo, the STZinduced mouse model of diabetes was used. Diabetes was induced
by intraperitoneal injection of STZ in WT (WT-DM) mice and
in Tg-DM mice to assess the effects of overexpression of GDNF.
Overexpression of GDNF in Tg-DM mice is driven by human
GFAP promoter, which is known to be expressed in astrocytes in
the central nervous system and some glial cells in the peripheral
nervous system. WT control (WT-C) and GFAP-GDNF Tg control
(Tg-C) mice were injected with vehicle.
WT-DM mice showed a significant decrease in body weight and
a significant increase in the level of blood glucose when compared
with WT-C mice 8 weeks after the induction of diabetes. The
weight of Tg-C mice was lower than that of the WT-C mice. The
Tg-DM mice showed a significant increase in serum glucose level
compared with WT-C and Tg-C mice (Table 1).
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apoptosis seen in the condition of diabetes was associated with
a decrease in PI3K signaling. Frozen cross sections of WT-C and
WT-DM mice ilea were assessed for myenteric neuronal p-Akt
expression. As shown in Figure 7, A–C, 8 weeks after the induction of diabetes, the WT-DM mice had significantly fewer p-Akt–
positive neurons in the myenteric ganglia compared with WT-C
mice. In addition, p-Akt was significantly reduced in myenteric
neurons isolated from the ilea of diabetic mice compared with
control mice as assessed by Western blot analysis using an antibody specific for p-Akt (Figure 7, D and E).
Diabetes is associated with loss of myenteric NADPH diaphorase–stained
neurons, and this is rescued by GDNF. Having demonstrated that diabetes is associated with enhanced apoptosis in enteric neurons, we
assessed the subtype of neurons affected in diabetes. Using wholemount analysis of mouse ilea, we assessed the neuronal NO synthase–containing (nNOS-containing) neurons (NADPH diaphorase stained), cholinergic neurons (choline acetyltransferase [ChAT]
stained), and the total number of neurons (peripherin stained and
PGP9.5 stained). The number of NADPH diaphorase–stained neurons, large and small fibers, was significantly decreased in WT-DM
mice after 8 weeks of diabetes compared with WT-C mice (Figure 8,
A–C). In the Tg-DM mice, the expression of GDNF ameliorated the
loss of NADPH diaphorase–stained neurons, large and small fibers.
No change in the number of acetylcholine esterase–stained excitatory neurons, large fibers or small fibers, was noted among all 4
groups of mice (Figure 8, D–F). This was confirmed by staining for
cholinergic neurons using an antibody specific for ChAT (Figure 9,
A and C). Total number of neurons was assessed by peripherin staining. The number of peripherin-positive neurons was significantly
decreased in WT-DM mice compared with WT-C mice. In Tg-DM
mice, the expression of GDNF ameliorated the loss of peripherinstained neurons (Figure 8, G and H). Total number of neurons was
also assessed by PGP9.5. The number of PGP9.5-positive neurons

Electron microscopy provides the most convincing evidence of
apoptotic cell death. A majority of the myenteric neurons from the
proximal colon of diabetic mice showed evidence of neuronal apoptosis with clumping of the chromatin, condensation of the nucleus,
mitochondrial ballooning, disruption of cristae, and disorganization
of the neuropil. In contrast, neurons from the proximal colon of control mice displayed normal (diffuse) chromatin staining in the nucleus, normal mitochondria, and an organized neuropil (Figure 5).
GDNF overexpression prevents diabetic enteric neuronal apoptosis. The
effect of GDNF on modulating the enteric neuronal apoptosis
seen in diabetes was assessed in vivo using the Tg-DM mice. Apoptosis was assessed by activated caspase-3 staining. Overexpression
of GDNF in the ilea of Tg-DM mice was confirmed by RT-PCR
(Figure 6A) and immunostaining using an antibody specific for
GDNF (Figure 6B). GFAP was used as a glial marker. These photographs show that GDNF expression was directed to the glial cells
in the enteric ganglia. Frozen cross sections of ilea from mice were
assessed for myenteric neuronal apoptosis using double-labeling
immunohistochemistry for cleaved caspase-3 and peripherin. Eight weeks after
the induction of diabetes, the WT-DM
5BCMF
mice had a significantly higher number
Characteristics of control and STZ-induced diabetic mice
of apoptotic neurons in the myenteric
ganglia compared with WT-C mice (FigBlood glucose
Blood glucose
Weight on the
Weight 8 weeks
ure 6, C and D). The percentage change
on the day of
8 weeks after
day of injection
after injection
in myenteric ganglia containing cleaved
injection (mg/dl)
injection (mg/dl)
(g)
(g)
caspase-3+/peripherin+ neurons comWT-C
158.5 ± 10.5
141.8 ± 0.8
41.25 ± 0.5
46.3 ± 2.1
pared with WT-C neurons is shown
43 ± 1.5
34 ± 2.3A
WT-DM
152.6 ± 6.2
465.5 ± 8.5C
Tg-C
145.5 ± 23.5
149 ± 0
32 ± 1.5B
35.3 ± 1.8
(Figure 6E). This increase in apoptosis is
Tg-DM
153.3 ± 11
593 ± 0D
36.3 ± 2
35.4 ± 5.5
ameliorated in the Tg-DM mice.
Diabetes is associated with decreased
#PEZXFJHIUBOECMPPEHMVDPTFMFWFMTPG85$ 85%. 5H$ BOE5H%.NJDFBSFTIPXOBUCBTFMJOF
expression of PI3K in enteric neurons. We
BOEXFFLTBGUFSJOEVDUJPOPGEJBCFUFT"1#1$1DPNQBSFEXJUI85$BUDPS
SFTQPOEJOHUJNFQPJOU%1DPNQBSFEXJUI5H$BUDPSSFTQPOEJOHUJNFQPJOU
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baseline. Transmural EFS (100 V, 20 Hz, 5 milliseconds, 60
seconds), which evoked relaxation of the proximal colon,
was significantly impaired in diabetic mice compared with
controls. The induction of diabetes in the Tg-DM mice did
not result in impairment of colonic relaxation (Figure 11A).
Representative tracing of an EFS-induced relaxation recording is shown in Figure 11B. These data support amelioration of inhibitory neuronal loss in diabetes in the presence
of GDNF overexpression. No change in the baseline amplitude of colonic contractions was noted between WT-C and
WT-DM mice. Measurement of rebound contraction after
relaxation with EFS was no different in all 4 mouse groups
(data not shown), indicating no significant differences in
the excitatory neuronal responses.
%JTDVTTJPO
The etiology of the gastrointestinal complications of diabetes
is multifactorial. There is evidence of damage to the ENS in
animal models of diabetes (13, 14) and in human diabetic
patients (10). In the current study, we examined the role of
hyperglycemia in inducing damage to the enteric neurons
and the underlying mechanism of this damage. Using an in
vitro culture system of enteric neurons as well as an in vivo
STZ-induced diabetic model, we demonstrated that hyperglycemia is associated with enteric neuronal apoptosis. Fur'JHVSF
ther, we demonstrated alteration in the PI3K pathway and a
%JBCFUFT JT BTTPDJBUFE XJUI FMFDUSPO NJDSPTDPQJD FWJEFODF PG NZFOUFSJD subsequent loss of inhibitory myenteric neurons in neuronal
OFVSPOBMBQPQUPTJT.ZFOUFSJDOFVSPOTGSPNUIFQSPYJNBMDPMPOTPGEJBCFUJD
cell culture as well as in diabetic mice. Importantly, we demNJDFTIPXFEFWJEFODFPGOFVSPOBMBQPQUPTJTXJUIDMVNQJOHPGUIFDISPNBUJO 
DPOEFOTBUJPOPGUIFOVDMFVT CMBDLBSSPX NJUPDIPOESJBMCBMMPPOJOHBOEEJT onstrated, for what we believe is the first time, that the neuSVQUJPOPGDSJTUBF CMVFBSSPXT BOEEJTPSHBOJ[BUJPOPGUIFOFVSPQJM*ODPOUSBTU  rotrophic factor GDNF reverses hyperglycemia-induced
DPOUSPMOFVSPOTEJTQMBZFEOPSNBMEJGGVTFDISPNBUJOTUBJOJOHJOUIFOVDMFVT neuronal apoptosis and loss of nNOS-containing neurons
HSFFOBSSPX OPSNBMNJUPDIPOESJB SFEBSSPXT BOEBOPSHBOJ[FEOFVSPQJM
and also improves gastrointestinal motility in diabetic mice.
Neuronal apoptosis has been shown to contribute to the
complications of diabetic retinopathy. Increased retinal
was significantly decreased in WT-DM mice compared with WT-C neuronal apoptosis leading to neurodegeneration has been demonmice. In Tg-DM mice, the expression of GDNF ameliorated the loss strated in a STZ-induced rat model of diabetes (34). Diabetes-related programmed cell death has been demonstrated in the hippocamof PGP9.5 (Figure 9, A and B).
Diabetic mice have delayed gastric emptying and increased intestinal tran- pus of type 1 BioBreeding/Worcester (BB/W) rats (35). Apoptotic
sit, and these changes are reversed by GDNF. Gastric emptying and intes- death in diabetic neuropathy has been related to hyperglycemia and
tinal transit were assessed in WT-C, WT-DM, Tg-C, and Tg-DM oxidative stress (20, 36, 37). In the human neuroblastoma cell line
mice as described in Methods. Figure 10A shows a representative SH-SY5Y, exposure to 20 mM glucose causes an increase in ROS,
photograph of the intestinal transit of methylene blue. As shown mitochondrial membrane depolarization, and cleavage of caspases
in Figure 10B, there was a significant delay in gastric emptying in (20). High glucose levels may result in depolarization of neurons
WT-DM mice (8 weeks of diabetes) compared with WT-C mice. This and increased intracellular calcium (38). This may be a mechanism
delay in gastric emptying was significantly improved in Tg-DM of glucotoxicity in enteric neurons, as they are known to be glucose
mice. The rate of intestinal transit 30 minutes after the admin- responsive and to express an ATP-sensitive K+-channel (30).
istration of methylene blue was significantly higher in WT-DM
Alterations in insulin signaling and tyrosine kinase activity as well
compared with WT-C mice. The presence of the GFAP-GDNF as reduction in neurotrophic factor support have been implicated
transgene in the diabetic mice (Tg-DM) reduced the rate of intes- in the pathophysiology of diabetic complications. In our study, we
tinal transit (Figure 10C).
have demonstrated that hyperglycemia decreased p-Akt both in cell
Diabetes is associated with impaired colonic relaxation in response to inhib- culture and in a diabetic animal model. These changes were reversed
itory neuronal stimulation, and these changes are reversed in the Tg-DM by the neurotrophic factor GDNF. Impaired retrograde transport of
mice. The effect of electric field–induced stimulation (EFS) of neurotrophic factors has been demonstrated in somatic and autoinhibitory neurons was assessed using isometric muscle tension nomic nerves in experimental diabetes. In STZ-induced diabetic
recording. The effect of inhibitory neurons was confirmed by rats, a decrease in the activation of the PI3K pathway was associperforming colonic longitudinal muscle strip stimulation in the ated with the impairment of retrograde nerve growth factor (NGF)
presence of atropine and guanethidine. Percentage relaxation was transport in the vagus nerve (29). GDNF alleviated the glucosecalculated by determining the difference between the maximal induced sensory deficits in a subset of sensory neurons called the
baseline force and the minimum force following electrical stimu- IB-4–positive nonpeptidergic, unmyelinated primary afferent neulation and expressing this as a percentage of the force generated at rons (39). Recently, the role of insulin and its antiapoptotic effects
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in hippocampal neurons was shown in a type 1 diabetic model (40).
The antiapoptotic effect of insulin is mediated through alteration of
the PI3K pathway, leading to activation of NF-κB (41). Recently, the
role of statins in the therapy of diabetic neuropathy involving the
sciatic nerve was shown. Rouvastatin, an HMG CoA reductase inhibitor, has a favorable effect on diabetic neuropathy that is independent of its cholesterol-lowering effect. It restored nNOS expression
in Schwann cells under high glucose conditions through activation
of the PI3K pathway, resulting in restoration of the microcirculation of the sciatic nerve (42). IGF-1 activation of the PI3K pathway results in protection from glucose-mediated apoptosis in this
model, and this protection is lost in the presence of the PI3K inhibitor LY294002 (43, 44). Growth factors such as NGF also block this
induction of ROS and stabilize the mitochondrial membrane potential (20). Therapy with nerve growth factor improves unmyelinated
fiber morphology and function in diabetic mice (45) and improves
sensation and sensory function in patients with diabetic neuropathy
(46). In a subpopulation of nonpeptidergic unmyelinated sensory
neurons, GDNF but not NGF administration can selectively reverse
deficits caused by diabetes (39). Our future studies will focus on the
signal transduction differences between NGF and GDNF in ameliorating diabetic neuropathy. Our findings demonstrate a reduction
in PI3K signaling in the enteric neurons in diabetes and the ability
of GDNF overexpression to ameliorate these findings. Further studies will need to be done in both diabetic animal and human tissue
samples to assess the levels of GDNF in enteric neurons.
The Journal of Clinical Investigation

Chronic hyperglycemia has been shown to impair PI3K signaling in skeletal muscle (29, 47). Amelioration of hyperglycemia
without alteration of insulin levels normalizes the PI3K activity in
skeletal muscle (29). Proper serum glucose control has been shown
to prevent or ameliorate the nerve damage responsible for diabetic
retinopathy and nephropathy (48, 49). In the current study, we
report the effects of hyperglycemia on a primary embryonic enteric
neuronal culture system. Hyperglycemia was shown to decrease
PI3K signaling, although the exact mechanism is not known and
needs to be further investigated. We also found a reduction in PI3K
signaling in adult myenteric neurons. Our findings in the enteric
neurons can be extended to adult neurons. We demonstrated the
role of hyperglycemia-induced changes in the PI3K pathway and
subsequent apoptosis and loss of enteric neurons. GDNF has also
been shown to activate the MAPK pathway (25). We have previously
reported that GDNF-mediated enteric neuronal survival is through
the PI3K pathway and not the MAPK pathway (26). Further studies
will need to be performed to evaluate the role of the MAPK pathway
in hyperglycemia-induced enteric neuronal damage.
The molecular mechanism of hyperglycemia’s alteration of PI3K
activity is not known. Possible mechanisms include phosphoinositide-dependent protein kinase-1 (PDK-1) and PDK-2 inhibition, activation of PI3-phosphatase that leads to a decrease in the cellular
contents of lipid products by PI3K, a defect in intracellular PI3K
translocation, and activation of a phosphatase that may modify
Akt/PKB activity (47). In cardiac myocytes, hyperglycemia results
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in a reduction in the level of IGF-1 receptor (50). Similar mechanisms may be associated with the reduced PI3K signaling noted in
our study. Another mechanism for reduced PI3K signaling in the
diabetic animals may be secondary to the weight loss noted in these
animals. Several factors contribute to the weight loss in diabetic animals, including glucosuria and diarrhea. In the diabetic Tg animals,
the absence of weight loss may be due to the correction of the gastrointestinal motility disturbances that are noted in these animals.
We have demonstrated that overexpression of GDNF in glial
cells adjacent to the enteric neurons results in an increase in NOcontaining inhibitory neurons. As previously shown, GDNF is efficiently secreted from astrocytes and acts in a paracrine fashion to
promote complete and long-lasting survival of injured neonatal
facial motor neurons (28). We believe that, similar to the effects of
GDNF in the central nervous system, where the astrocytes secrete
GDNF to affect motor neurons, the GDNF in the glial cells is
secreted adjacent to enteric neurons. The NADPH diaphorase–
containing neurons could be inhibitory neurons, interneuronal
neurons, or primary afferent neurons. Loss of nNOS-containing
neurons in diabetes can result in delayed gastric emptying due to
loss of neurons in the pylorus and accelerated intestinal transit
due to loss of inhibition influence of these neurons in the small
and large intestines. The defective gastric accommodation is due
to impaired NOS expression in the gastric myenteric plexus in
the spontaneously diabetic BB/W rat model (51). Delayed gastric
emptying in diabetes is secondary to loss of neuronal NOS expression and function (12). Cellek et al. demonstrated loss of nitrergic
function and neurons in the penises and pylori of STZ-treated
diabetic rats, and only the loss of nNOS content and function was
reversible by insulin, not the neuronal loss (52, 53). Our results
show loss of nNOS-containing neurons in the intestine, which
can contribute to the increased intestinal transit seen in diabetes.
GDNF can prevent the enteric neuronal loss and ameliorate the
increased intestinal transit in diabetes. Thus, the activation of the
PI3K pathway can prevent the loss of nNOS-containing neurons
seen in diabetes. We did not see a change in the cholinergic neurons in diabetes. This may reflect the duration of diabetes that we
examined in our experiments.
Insulin improves the delayed gastric emptying seen in the STZ
model of diabetes at 8 weeks (12). We now demonstrate that
GDNF can perform a similar function by increasing the number of
NADPH diaphorase–containing neurons. Other gastrointestinal
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problems in diabetes include diabetic diarrhea and constipation.
The reduction in intestinal NADPH diaphorase–containing neurons and subsequent increase in intestinal transit can contribute
to this diarrhea. NO-related mechanisms regulate human small
intestinal motility (54). Symptoms of diabetic gastroparesis and
diabetic diarrhea can worsen in patients with poor glucose control. Thus, both acute and chronic hyperglycemia can affect gastrointestinal motility, and we believe that alteration in the PI3K
pathway can contribute to this. Loss of nNOS-containing enteric
neurons has been noted in conditions of congenital pyloric stenosis, achalasia, and Hirschsprung disease (25). The regulation of
the PI3K pathway may be altered in these conditions, and this area
needs to be further investigated.
Our finding of reduced nitrergic neurons in diabetic neuropathy
has potential therapeutic implications. Currently, the major drugs
used for treating patients with diabetic gastropathy include domperidone (dopaminergic antagonist), metachlopramide (55), and
erythromycin. Knowledge of the specific molecular mechanisms of
hyperglycemia-induced enteric neuronal damage may have significant implications in the design and testing of therapeutic regimens
for diabetic enteric neuropathy. Our results demonstrate the role of
the PI3K pathway on hyperglycemia-induced neuronal loss. GDNF
reverses the morphological and functional effects of hyperglycemia
on enteric neuronal survival and may be a potential therapeutic target for gastrointestinal motility disorders in diabetes.
.FUIPET
Materials. The components for primary culture were bovine insulin, bovine
serum albumin fraction V, fetuin selenium, putrescine, and progesterone;
all were obtained from Sigma-Aldrich. Also used were dispase and collagenase (CLS4; Worthington Biochemical Corp.), rat transferrin (ChromPure;
Jackson ImmunoResearch Laboratories Inc.), 8-well culture slides and 6-well
plates coated with poly-D-lysine and laminin (BD Biosciences), and prefilter
and columns for magnetic separation (Miltenyi Biotec).
We also used the following: antibodies to low-affinity NGF receptor
(p75NTR, clone192; Chemicon International, MAB365), c-Ret (ImmunoBiological Laboratories Inc.), peripherin for immunocytochemistry (Chemicon International, MAB1527), Akt (Cell Signaling Technology), peripherin
for whole mount (Chemicon International, AB1530), p-Akt for Western
blotting (Cell Signaling Technology), p-Akt for immunocytochemistry
(Promega), rabbit IgG, HRP–linked (Cell Signaling Technology), FOXO3a
(FKHRL1, Upstate USA Inc.), cleaved caspase-3 (Cell Signaling Technology),

http://www.jci.org

Volume 116

Number 2

February 2006

Downloaded on July 12, 2013. The Journal of Clinical Investigation. More information at www.jci.org/articles/view/26295

SFTFBSDIBSUJDMF

'JHVSF
%JBCFUFTJTBTTPDJBUFEXJUIMPTTPGNZFOUFSJD/"%1)EJBQIPSBTFmTUBJOFEOFVSPOT BOEUIJTJTSFTDVFECZ(%/'5IFNZFOUFSJDQMFYVTFTBOE
UIFMPOHJUVEJOBMNVTDMFMBZFSTGSPN85$ 85%. 5H$ BOE5H%.NJDFXFSFTFQBSBUFEGSPNUIFSFTUPGUIFJOUFTUJOFTBOEVTFEGPSTUBJOJOH
" 3FQSFTFOUBUJWFQIPUPHSBQITPG/"%1)EJBQIPSBTFmTUBJOFEOFVSPOT #BOE$ 1FSDFOUBHFDIBOHFJOUIFOVNCFSPG/"%1)EJBQIPSBTFm
TUBJOFEOFVSPOT # BOEMBSHFBOETNBMMGJCFST $ SFMBUJWFUP85$ % 3FQSFTFOUBUJWFQIPUPHSBQITPGBDFUZMDIPMJOFFTUFSBTFmTUBJOFEOFVSPOT
&BOE' 1FSDFOUBHFDIBOHFJOUIFOVNCFSPGBDFUZMDIPMJOFFTUFSBTFmTUBJOFEOFVSPOT & BOEMBSHFBOETNBMMGJCFST ' SFMBUJWFUP85$ ( 
3FQSFTFOUBUJWFQIPUPHSBQIPGQFSJQIFSJOTUBJOFEOFVSPOT ) 1FSDFOUBHFDIBOHFJOUIFOVNCFSPGQFSJQIFSJOTUBJOFEOFVSPOTSFMBUJWFUP85$
"TEFTDSJCFEJO.FUIPET UIFOVNCFSPGOFVSPOTSFQSFTFOUTBTVNPGUIFOFVSPOTTDPSFEJOHSJETBU×NBHOJGJDBUJPO 1 1
4DBMFCBSTμ. "BOE% μN ( 

GDNF and GFAP (Santa Cruz Biotechnology Inc.), goat anti-mouse, FITClabeled, donkey anti-rabbit biotin, donkey anti-mouse biotin, and peroxidase-conjugated streptavidin (Jackson ImmunoResearch Laboratories Inc.).
Other reagents were as follows: tyramide signal amplification kit
(TSA-FITC or TSA-Cy3, NEN Life Science Products), Hoechst 33258
(Sigma-Aldrich), TUNEL Kit (Roche Diagnostics Corp.), STZ (SigmaAldrich), methylene blue (Mayne Pharma), dextrose (Sigma-Aldrich),
mannitol (Fisher Diagnostics), PicoPure RNA Isolation Kit (Arcturus),
Omniscript Reverse Transcription Kit (QIAGEN) and random hexamers (Invitrogen Corp.), Taq DNA polymerase (Promega), p-EGFP vector
(BD Biosciences), CA-Akt construct (kind gift from Phil Stahl, Washington University, St. Louis, Missouri, USA), and lipofectamine 2000
(Invitrogen Corp.). GDNF was produced as previously described (56)
and stored at –70°C in aliquots. Fluorescent photomicrographs were
The Journal of Clinical Investigation

obtained on a Leica microscope. Certain images were also taken using a
Zeiss LSM 510 confocal microscope. Electron microscopic images were
taken using a Hitachi H-7500 transmission electron microscope.
Primary culture and magnetic bead immunoselection of p75-expressing cells.
Stomachs and small and large bowels from E14.5 Sprague-Dawley rat
embryos (10–12 embryos) were dissociated with collagenase and dispase
to prepare a single-cell suspension, as previously described (23, 57). In
brief, the dissociated cells were incubated with a monoclonal antibody to
low-affinity NGF receptor (p75NTR, 10 μg/ml), washed, and labeled with
goat anti-mouse IgG microbeads (50-nm diameter; Miltenyi Biotec). Cells
expressing p75 bound to the microbeads were retained in the presence of a
magnetic field (0.6 Tesla) while the remainder of the cells passed through.
To collect the retained cells, the column was removed from the magnetic
field, and the immunoselected cells were eluted from the column. The yield
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800 Ret-expressing neurons from 4 independent experiments
were scored in a blinded fashion to determine the percentage of
Hoechst+/Ret+ cells. To visualize TUNEL-positive cells, slides were
washed in PBS and then incubated with FITC-labeled dUTP in
the presence of terminal deoxynucleotidyl transferase (TdT) for 1
hour at 37°C. We scored 400 RET-expressing neurons in a blinded
fashion to determine the percentage of TUNEL+/Ret+ cells.
Analysis of Akt phosphorylation. p75 immunoselected enteric neurons were cultured in N2 medium containing 5 or 20 mM glucose
and in the presence or absence of GDNF (100 ng/ml) for 24 hours.
Cultures were fixed in 4% paraformaldehyde (30 minutes, 25°C)
and then permeabilized with 0.1% Triton-X 100 and 0.1% sodium
citrate in PBS (2 minutes on ice). p-Akt–positive cells were visualized using an antibody specific for the phosphorylated form of Akt
(p-Akt473; 1:100 dilution, 4°C, overnight), followed by secondary
antibodies and the TSA-Cy3 detection method as described above
for Ret immunocytochemistry. Peripherin was used as a counterstain to identify neurons by using a TSA-FITC detection method.
At least 800 peripherin-expressing neurons from 4 independent
experiments were scored in a blinded fashion, and the percentage
of p-Akt–positive cells was determined using Scion Image beta
4.0.2 software (Scion Corp.) to quantitate fluorescence.
Forkhead translocation. Immunoselected enteric neurons were
cultured in N2 medium containing 5 or 20 mM glucose and in the
presence or absence of GDNF (100 ng/ml) for 24 hours. Cells were
then fixed (4% paraformaldehyde, 30 minutes, 25°C) and permeabilized with 0.1% Triton-X 100 and 0.1% sodium citrate in PBS
(2 minutes on ice). Immunocytochemistry was first performed
with a primary antibody to FOXO3a (1:100) and a TSA-Cy3 kit as
'JHVSF
described above. Cells were then stained with an anti-peripherin
"TTFTTNFOUPG1(1BOE$I"5TUBJOFEOFVSPOTJO85BOE5HNJDF " 
antibody and a TSA-FITC kit. At least 800 peripherin-expressing
3FQSFTFOUBUJWFQIPUPHSBQITPGDSPTTTFDUJPOTPGJMFBGSPNNJDFTUBJOFEGPS
1(1 SFE BOE$I"5 HSFFO  #BOE$ 1FSDFOUBHFDIBOHFJOUIFOVNCFS neurons from 4 independent experiments were scored in a blindPGHBOHMJBTUBJOJOHQPTJUJWFGPS1(1 # BOE$I"51(1 $ SFMBUJWFUP ed fashion, and the percentage of peripherin-expressing neurons
85$JTTIPXO"UPUBMPGJOEFQFOEFOUFYQFSJNFOUTXBTQFSGPSNFE 1 with forkhead localized in the nucleus was determined using
Scion Corp. imaging software to quantitate fluorescence.
14DBMFCBSTμ.
CA-Akt transfection method. The role of Akt in rescuing the hyperglycemia-induced apoptosis in enteric neurons was confirmed by
of immunoselected cells, calculated from several consecutive experiments, transfecting the cells with CA-Akt. CA-Akt lacks amino acid 4-129 and has
averaged 0.8–1.0 × 106 cells (approximately 10% of the total cells). Follow- a 14–amino acid src myristoylation signal on the amino terminus of Akt
ing immunoselection, cells were resuspended in modified N2 medium, and that targets Akt to the membrane (33). Enteric neurons were cultured in
12,500 trypan blue–excluding cells in 125 μl of N2 medium were plated the presence of GDNF (100 ng/ml) for 24 hours. Medium was replaced
into a single well of an 8-well slide coated with poly-D-lysine and laminin. with either 5 or 20 mM glucose, and the cells were transfected with control
An additional 125 μl of medium was added to each well with the desired p-EGFP construct (p-EGFP; 0.473 μg/μl) or a CA-Akt construct (CA-Akt;
factors. Cells were grown in the medium in a humidified tissue culture 3.962 μg/μl) with p-EGFP for 24 hours, using Lipofectamine 2000 per
incubator containing 5% CO2 at 37°C. Unless otherwise stated, cells were manufacturer’s protocol. Cells were fixed and assessed for apoptosis by
grown in the presence of GDNF (100 ng/ml). As described by other inves- the Ret/TUNEL double-labeling method as described above.
STZ-induced diabetes mellitus in mouse model. All animal studies were approved by
tigators (58), our immunoselection method yielded a population of 80%
Ret-positive cells after 24 hours of culture. The p75-negative fraction had the Emory University Institutional Review Board. Tg-DM mice were generated
by cloning the full-length mouse GDNF cDNA into the pGFAP–human growth
less than 10% Ret-positive cells.
Ret/Hoechst and Ret/TUNEL double labeling. Enteric neurons were treated hormone expression cassette containing a 2.2-kb fragment of the human GFAP
with different glucose concentrations (5, 10, or 20 mM glucose or 5 mM glu- promoter. Generation and characterization of these mice is described elsewhere
cose plus 15 mM mannitol) in the presence or absence of GDNF (100 ng/ml) (28). Integration of the transgene into the mouse genome was determined by
in serum-free/glucose-free medium and maintained in culture for 24 hours. PCR on genomic DNA extracted from mouse tail using forward (5′-AGCTNeurons were fixed with 4% paraformaldehyde (pH 7.35, 30 minutes, 25°C), CACTGCAGCCTCACCTACT-3′) and reverse (5′-CAGGCATATTGGAGTand permeabilized with 0.1% Triton-X 100, 0.1% sodium citrate in PBS (pH CACTGG-3′) primers in conditions described previously (28).
These mice overexpressed GDNF in both the central nervous system
7.4; 2 minutes on ice). Staining for c-Ret was performed using a rabbit
anti c-Ret primary antibody (1:100) in conjunction with a tyramide signal and the peripheral nervous system. The Tg-DM mice at birth exhibited
amplification kit (1:100, TSA-Cy3) as described previously (26). To visual- an obvious tremor. The tremor gradually reduced with maturation and
ize Hoechst-positive cells, slides were washed in PBS and then incubated was undetectable after 2–3 weeks of age. The tremor may be a reflection of
with Hoechst stain (2.5 μg/ml) for 3 minutes at room temperature. At least the transiently hyperinnervated neuromuscular junctions, and its disap
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30 seconds at 60°C, and 45 seconds at 72°C. A
final extension for 7 minutes at 72°C was performed before cooling to 4°C. The reaction was
analyzed on a 2% ethidium bromide–stained
agarose gel, and the amplified products were
visualized by UV transillumination.
Assessment of apoptosis and Akt phosphorylation
in mouse ilea. Ilea immediately adjacent to the
cecum were obtained from WT-C, WT-DM,
Tg-C, and Tg-DM mice and fresh frozen in
OCT on dry ice. Frozen sections of 6 μm were
obtained and fixed in 4% paraformaldehyde
(pH 7.35, 30 minutes, 25°C), followed by permeabilization with 0.1% Triton-X 100 and
0.1% sodium citrate in PBS (pH 7.4, 2 minutes
on ice). Staining for cleaved caspase-3 was
performed using a rabbit anti-cleaved caspase-3 (Asp175) polyclonal antibody (1:100)
in conjunction with a tyramide signal amplification kit (1:100, TSA-Cy3) as described
previously (26). Sections were rinsed with
PBS and blocked with 2% BSA in PBS (1 hour,
room temperature) and then double labeled
'JHVSF
"TTFTTNFOUPGHBTUSJDFNQUZJOHBOEJOUFTUJOBMUSBOTJU " 1IPUPHSBQIPGTUPNBDIBOEJOUFTUJOF for peripherin using a mouse anti-periphGSPN85$NPVTFNJOVUFTBGUFSBENJOJTUSBUJPOPGNFUIZMFOFCMVFEZF3FEBSSPXTIPXT erin antibody (1:100) in conjunction with a
UIFNBYJNVNUSBOTJUPGNFUIZMFOFCMVF # (BTUSJDFNQUZJOHXBTBTTFTTFENJOVUFTBGUFS goat anti-mouse FITC-linked antibody. Fifty
BENJOJTUSBUJPOPGNFUIZMFOFCMVFJO85$ 85%. 5H$ BOE5H%.NJDF BTEFTDSJCFEJO
peripherin-positive ganglia per section were
.FUIPET $ *OUFTUJOBMUSBOTJUXBTBTTFTTFENJOVUFTBGUFSBENJOJTUSBUJPOPGNFUIZMFOFCMVF
BOEFYQSFTTFEBTBQFSDFOUBHFPGUIFUPUBMJOUFTUJOBMMFOHUI BTEFTDSJCFEJO.FUIPETO scored in a blinded fashion to determine the
percentage of caspase+/peripherin+ ganglia. At
BOJNBMTJOFBDIHSPVQ 1 1
least 6 sections were scored for each condition
in 3 separate mice.
pearance correlates with gradual loss of multiple innervation of skeletal
For p-Akt/peripherin double labeling, a similar staining protocol was used,
muscles (28). These mice weighed 20% less than age-matched littermate and the primary antibody rabbit anti-pS473 Akt antibody (1:100) was used.
controls. Despite this weight loss, eye opening, fur growth, weaning, and Fifty peripherin-positive ganglia per section were scored in a blinded fashion
reproduction capacity were comparable to control. These mice were fed to determine the percentage of p-Akt+/peripherin+ ganglia. At least 6 sections
ad libitum. Eight-week-old male Tg-C and WT-C littermates were injected were scored for each condition in 3 separate mice.
intraperitoneally with either STZ in 0.05 M citrate buffer, pH 7.4 (200 mg/kg),
GFAP/GDNF double labeling. GDNF overexpression in Tg mice was further
or vehicle alone. Blood glucose and weight of the mice were measured prior confirmed by immunohistochemistry. Sections were fixed as described
to injection as well as 48 hours and 8 weeks after injection of STZ, and the above and blocked with 5% BSA (in PBS), and WT-C and Tg-C mouse secaverages are shown in Table 1 (48-hour measurement not shown).
tions were stained for GDNF using a rabbit anti-GDNF (1:50 in 1% BSA)
Electron microscopy. Proximal colon tissue was obtained from WT-C and and TSA-Cy3 kit as described above. Sections were then counterstained
WT-DM mice and fixed with 2.5% glutaraldehyde in 0.1 M cacodylate buffer, with a goat anti-GFAP antibody (1:50) in conjunction with a donkey antipH 7.2, overnight at 4°C, followed by 3 washes with the same buffer. Sam- goat FITC lined antibody. GFAP was used as a glial cell marker. At least 5
ples were then treated with 1% osmium tetroxide in 0.1 M cacodylate buffer sections were scored for WT-C and Tg-C mice.
for 1 hour at room temperature. After fixation with osmium, samples were
Isolation (and protein extraction) of myenteric plexus from ilea of control and diadehydrated through an ascending ethanol series and embedded with epoxy betic mice. WT-C and WT-DM mice ilea were collected in chilled L-15 mediresin. Ultrathin sections were stained with uranyl acetate and lead citrate and um and were cut into 1.0–1.5–cm segments. Strips of longitudinal muscle
examined with a Hitachi H-7500 transmission electron microscope.
with attached myenteric ganglia were dissected under a dissecting microRT-PCR. Total RNA was isolated from whole-ileum tissue of WT-C and Tg-DM scope and collected in L-15 medium on ice. The tissue was then transferred
mice using the PicoPure RNA Isolation Kit reagents (Arcturus), and 1 μg to a tube containing 2 ml of collagenase, type II (1 mg/ml) in HBSS and
RNA was reverse transcribed into first-strand cDNA using Omniscript reverse incubated for 90 minutes. In step 1, the tube was vortexed for 20 seconds.
transcriptase (QIAGEN) and random hexamers (Invitrogen Corp.). Transgene The partially digested tissue was allowed to settle and supernatant was colmRNA was detected by RT-PCR using a set of primers that detect only the lected and then screened under a dissecting microscope for myenteric ganmRNA transcribed from the Tg construct (28, 59). As an internal control, we glia or cells and spun down at 1,150 g for 10 minutes at 4°C. In step 2, the
used primers specific to the GAPDH housekeeping gene. For semiquantitative cells were suspended in about 1 ml of L-15 medium and kept on ice. Fresh
PCR, 25 μl reactions were set up, comprising ×1 Taq DNA polymerase buffer, collagenase solution (1 ml) was added to the remaining partially digested
1.5 mM MgCl2, 200 μM dNTP mix, 0.4 μM each of the GDNF or GAPDH pieces and incubated at 37°C for 30 minutes. This process was repeated 2–3
oligonucleotide primers, 1.25 U Taq DNA polymerase, and 1 μl first-strand times. Steps 1 and 2 were repeated after every incubation, and cells were colcDNA. The samples were heated for 3 minutes at 95°C and subjected to 30 lected in the same tube. This process resulted in most of the myenteric plexcycles of PCR amplification, each cycle consisting of 30 seconds at 95°C, us being removed from the smooth muscle and collected (60, 61). The cells
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were spun down, the supernatant removed completely, and the cells were
washed in L-15 medium followed by ice-cold PBS. Lysis buffer (50–80 μl
containing 1 mM PMSF and 100 nM okadaic acid) was added to the pellet,
kept on ice for 5 minutes, sonicated 4 times for 5 seconds each on ice, and
microcentrifuged for 10 minutes at maximum speed (15,700 g). Then the
supernatant cell lysate was transferred to a new Eppendorf tube and stored
at –80°C. Protein was measured by the Lowry method.
Western blotting. For each lane, 6 μg of protein was loaded onto a 12%
Tris-HCl gel. Western blotting for p-Akt was performed as described (62). A
semiquantitative measurement of the band intensity was performed using
the Scion imaging computer software program and expressed as pixel
intensity per unit area.
Whole mount. Small bowel was dissected from mice, and the mesentery
was removed. Three pieces of ileum (4 cm; labeled 1, 2, and 3, 1 being the
closest to the cecum) were cut along the mesentery and pinned down
flat onto a glass dish with silicone coating. The intestines were fixed
in 4% paraformaldehyde (1 hour, room temperature). The myenteric
plexus and the longitudinal muscle layer were separated from the rest of
the intestine and used for staining. Ileum piece 1 was used for peripherin staining, 2 for NADPH diaphorase, and 3 for acetylcholine esterase
staining. For NADPH diaphorase staining, the fixed tissue was washed
in PBS and incubated in diaphorase solution (β-NADPH diaphorase,
1 mg/ml; nitroblue tetrazolium, 0.1 mg/ml; and 0.3% Triton-X 100
in PBS) for 1 hour at 37ºC. This was followed by washing in PBS and
mounting of the tissue on a glass slide. For acetylcholine esterase staining, the fixed tissue was washed in PBS and incubated in fresh copper
buffer solution (100 ml dH2O, 7.2 mg ethopropazine, 115.6 mg acetylthiocholine iodide, 75.0 mg glycine, 50.0 mg copper sulfate pentahydrate, 885.0 mg sodium acetate trihydrate; pH to 5.6 with glacial acetic
acid) for 2 hours. This was followed by a wash in dH 2O, 1 minute in
1.25% sodium sulfide nonahydrate solution, a second wash in dH 2O,
then mounting of the tissue on a glass slide. Peripherin staining was
performed on the fixed intestinal tissue using a rabbit anti-peripherin
polyclonal antibody (1:500) in conjunction with a tyramide signal amplification kit (1:100, TSA-Cy3) as described previously (63).
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Myenteric fiber count was performed on both NADPH diaphorase and
acetylcholine esterase–stained intestines by counting fibers crossing a
0.1 mm2 grid with 10 horizontal and 10 vertical lines. Twenty randomly
selected fields per mouse were evaluated from 4 animals of each genotype. The neurons were counted within the 0.1 mm2 grid. Total number
of neurons was expressed as peripherin-positive neurons per grid. Data
were analyzed using the InStat software (version 2.04; GraphPad) in conjunction with ANOVA.
Immunohistochemistry for ChAT and PGP9.5. Frozen sections (6 μm) were
obtained from WT-C, WT-DM, Tg-C, and Tg-DM mice and fixed and
permeabilized as described above. For PGP9.5 staining, the sections were
blocked in 10% normal donkey serum and incubated with primary antibody (PGP9.5, 1:2000, in 1% normal donkey serum) for 24 hours followed
by detection with the TSA-Cy3 secondary detection system as described
above. For ChAT staining, the sections were blocked with 5% BSA and incubated overnight in 1:100 primary antibody in 1% BSA. Secondary detection was performed by incubation with an Alexa Fluor 488 rabbit anti-goat
antibody (1:500) dilution. Three randomly selected fields per section were
evaluated in a blinded fashion from at least 5 sections per mouse.
Measurement of intestinal transit and gastric emptying. WT-C, WT-DM, Tg-C,
and Tg-DM mice received an injection of 0.1 ml of methylene blue–labeled
10% dextrose solution, using oral gavage. At the indicated time (5 or 30
minutes), mice were sacrificed. The stomach was clamped with a string
above the lower esophageal sphincter and a string beneath the pylorus
to prevent leakage of methylene blue. The intestinal transit was measured from the pylorus to the most distal point of migration of methylene blue. The total length of the small intestine was measured, and the
transit time was expressed as percentage of total intestinal length as well
as cm migration of methylene blue (12, 64). The stomach was cut just
beneath the strings and frozen at –70°C until measurement of gastric
emptying. Gastric emptying of liquids was determined as described previously (12, 64). Excised stomachs were minced and homogenized for 30
seconds in 15 ml of 0.1 N sodium hydroxide. An additional 5 ml of 0.1 N
sodium hydroxide was added and kept at room temperature for 1 hour.
Supernatant (5 ml) was then centrifuged at 1,250 g for 20 minutes at
4°C. Absorbance of the samples was read at a wavelength of 570 nm.
The stomach and its contents obtained from mice sacrificed at the
5-minute time point (after orogastric administration of methylene blue)
served as a reference stomach measurement. The percentage of gastric
emptying was calculated by the following formula: [(A570 reference
— A570 sample)/A570 reference] × 100. Gastric emptying of methylene
blue was expressed as the percentage of gastric emptying of the sample
compared with the reference stomach. Retro-orbital blood samples were
obtained from mice before and 30 minutes after gavage with methylene
blue and the serum assessed for methylene blue. No methylene blue was
detected in the serum of mice fed with methylene blue. We also correlated
the gastric emptying assessed by methylene blue with that of a colloidal
suspension (charcoal) and found similar results.
Isometric muscle recording. Longitudinal muscle strips were obtained from
the proximal colons of WT-C, WT-DM, Tg-C, and Tg-DM mice. The strips
were mounted between 2 hooks and placed between 2 platinum electrodes
in 50 ml chambers containing Krebs buffer (NaCl, 118 mM; KCl, 4.7 mM;
KH2PO4, 1.2 mM; MgCl2, 1.2 mM; NaHCO3, 23 mM; EDTA, 0.3 mM;
glucose, 10 mM; and CaCl2, 2.5 mM; pH 7.4) at 37°C and continuously
gassed with 95% O2 and 5% CO2. Tension was monitored with an isometric force transducer and recorded using the PowerLab recording software
(version 5.2.1; ADInstruments). The intestinal strips were equilibrated for
1 hour with 4.9 mN of tension applied. The colonic relaxation measured
in response to transmural stimulation was recorded by EFS (100 V, 20 Hz,
5 millisecond pulse for a duration of 30 seconds) in the presence of atropine
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(1 μM) and guanethidine (1 μM). For quantitative determination of relaxation, we used intestinal strips from any given treatment condition and
used the first relaxation under that condition. The NO dependence of the
relaxation was confirmed by incubation with L-NAME prior to EFS. This
relaxation was completely abolished by tetrodotoxin (10–7 M) which indicated mediation by a neuronal pathway. L-NAME (10–4 M) significantly
reduced NANC by 70%, suggesting that muscle relaxation was primarily
mediated by NO production from the myenteric plexus.
Statistics. Results are expressed as mean ± SEM. The data for all experiments
was compared using a 2-tailed Student’s t test, assuming unequal variance.
P values of less than 0.05 were considered to be statistically significant.
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